Placebo control group in COVID-19 vaccine trials: context and timing matters.
作者信息
Dal-Ré Rafael
机构信息
Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
出版信息
Eur J Clin Pharmacol. 2022 Mar;78(3):523-526. doi: 10.1007/s00228-021-03259-x. Epub 2021 Nov 27.
Abstract
摘要
相似文献
1
Placebo control group in COVID-19 vaccine trials: context and timing matters.新冠疫苗试验中的安慰剂对照组：背景和时机很重要。
Eur J Clin Pharmacol. 2022 Mar;78(3):523-526. doi: 10.1007/s00228-021-03259-x. Epub 2021 Nov 27.
2
COVID-19 vaccine trials: The potential for "hybrid" analyses.COVID-19 疫苗试验：“混合”分析的可能性。
Clin Trials. 2021 Aug;18(4):391-397. doi: 10.1177/17407745211018613. Epub 2021 May 27.
3
Placebo-controlled trials with COVID-19 vaccines: participants first.COVID-19疫苗的安慰剂对照试验：参与者至上。
J Clin Epidemiol. 2021 Oct;138:211-212. doi: 10.1016/j.jclinepi.2021.07.004. Epub 2021 Jul 13.
4
Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical?当前高收入国家的新冠疫苗试验：安慰剂对照试验是否符合伦理道德？
Clin Microbiol Infect. 2021 Nov;27(11):1565-1567. doi: 10.1016/j.cmi.2021.08.005. Epub 2021 Aug 8.
5
Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.在初始候选疫苗获得紧急使用授权或批准上市后评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗
JAMA. 2021 Jan 19;325(3):221-222. doi: 10.1001/jama.2020.25127.
6
COVID-19 vaccine trials: The use of active controls and non-inferiority studies.COVID-19 疫苗试验：活性对照和非劣效性研究的应用。
Clin Trials. 2021 Jun;18(3):335-342. doi: 10.1177/1740774520988244. Epub 2021 Feb 3.
7
Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.继续批准在低收入和中等收入国家进行安慰剂对照的新冠疫苗试验的基本原理。
Lancet. 2021 Mar 6;397(10277):878. doi: 10.1016/S0140-6736(21)00357-3. Epub 2021 Feb 19.
8
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
9
Placebo use in vaccine trials: recommendations of a WHO expert panel.疫苗试验中安慰剂的使用：世界卫生组织专家小组的建议
Vaccine. 2014 Aug 20;32(37):4708-12. doi: 10.1016/j.vaccine.2014.04.022. Epub 2014 Apr 25.
10
Placebo-controlled trials of Covid-19 vaccines - Are they still ethical?新冠疫苗的安慰剂对照试验——它们在伦理上是否仍然可行？
Indian J Med Ethics. 2021 Apr-Jun;VI(2):1-8. doi: 10.20529/IJME.2021.015.
本文引用的文献
1
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.针对有症状和无症状 SARS-CoV-2 感染的保护相关因素。
Nat Med. 2021 Nov;27(11):2032-2040. doi: 10.1038/s41591-021-01540-1. Epub 2021 Sep 29.
2
COVID-19: release approved vaccines for trials of new ones.新冠疫情：批准已获许可的疫苗用于新疫苗试验。
Nature. 2021 Sep;597(7875):178. doi: 10.1038/d41586-021-02398-6.
3
Restrictions on the use of placebo in new COVID-19 vaccine trials.新型冠状病毒肺炎疫苗新试验中安慰剂使用的限制
Eur J Clin Pharmacol. 2022 Jan;78(1):147-148. doi: 10.1007/s00228-021-03203-z. Epub 2021 Aug 30.
4
Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical?当前高收入国家的新冠疫苗试验：安慰剂对照试验是否符合伦理道德？
Clin Microbiol Infect. 2021 Nov;27(11):1565-1567. doi: 10.1016/j.cmi.2021.08.005. Epub 2021 Aug 8.
5
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.对新型冠状病毒肺炎疫苗试验安慰剂组参与者解除盲法并接种疫苗的伦理考量
Front Public Health. 2021 Jun 24;9:702960. doi: 10.3389/fpubh.2021.702960. eCollection 2021.
6
COVID vaccines to reach poorest countries in 2023 - despite recent pledges.尽管近期有承诺，但新冠疫苗要到2023年才能抵达最贫穷国家。
Nature. 2021 Jul;595(7867):342-343. doi: 10.1038/d41586-021-01762-w.
7
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性：医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
8
Evidence for antibody as a protective correlate for COVID-19 vaccines.针对 COVID-19 疫苗，抗体作为一种保护相关因素的证据。
Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.
9
Randomized COVID-19 vaccination rollout can offer direct real-world evidence.随机的 COVID-19 疫苗接种推广可以提供直接的真实世界证据。
J Clin Epidemiol. 2021 Oct;138:199-202. doi: 10.1016/j.jclinepi.2021.05.014. Epub 2021 May 25.
10
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.正在进行和未来的 COVID-19 疫苗临床试验：挑战与机遇。
Lancet Infect Dis. 2021 Nov;21(11):e342-e347. doi: 10.1016/S1473-3099(21)00263-2. Epub 2021 May 18.
Zotero 插件